On the other hand, Sverrisdottir et al. performed a randomized controlled trial (RCT) of 285 premenopausal breast cancer patients and demonstrated that the group that received a GnRH-a had higher rates of resumption of menses compared to the control [6]. The gene discussed is GNRH1; the disease is breast carcinoma.